Cargando…
CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is a major type of NSCLC and has high morbidity and mortality. The identification of useful prognostic biomarkers for LUAD is important. CBX7 has been reported in various cancers yet its expression level and potential roles have not been fully understood. METHO...
Autores principales: | Yang, Yanlong, Hu, Zaoxiu, Sun, Hongwen, Yu, Qinghe, Yang, Linzhu, Yin, Fang, Sun, Yongmen, Pu, Lisha, Zhu, Xingming, Li, Shen, Chen, Xiaobo, Zhao, Yunping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714415/ https://www.ncbi.nlm.nih.gov/pubmed/34992383 http://dx.doi.org/10.2147/OTT.S325203 |
Ejemplares similares
-
Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer
por: Li, Xinxin, et al.
Publicado: (2023) -
Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration
por: Zhang, Chun, et al.
Publicado: (2021) -
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
por: Niu, Hongjuan, et al.
Publicado: (2022) -
Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer
por: Shi, Tongdong, et al.
Publicado: (2023) -
MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study
por: Hu, Zaoxiu, et al.
Publicado: (2019)